Community curated by people like you

Type 1 diabetes stories

Sep 17, 2026

FDA approves finerenone for chronic kidney disease in type 1 diabetes

The FDA approved finerenone (Kerendia) for treating chronic kidney disease associated with type 1 diabetes, marking the first new drug approval for this indication in decades.

Sep 17, 2026·2 sources

00

Top claims

▪The FDA approved finerenone (Kerendia) on September 17, 2026, for the treatment of adults with chronic kidney disease associated with type 1 diabetes
▪Finerenone is the first new treatment approved for chronic kidney disease in adults with type 1 diabetes in more than 30 years
▪Anne L. Peters, MD, highlighted that concerns about diabetic ketoacidosis with SGLT2 inhibitors may limit the use of those medications in patients with type 1 diabetes and chronic kidney disease

Topics

Metabolic health Drug Approval and Clinical Trials

Related entities

Chronic kidney disease